Welcome to our dedicated page for Traccom news (Ticker: TRCC), a resource for investors and traders seeking the latest updates and insights on Traccom stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Traccom's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Traccom's position in the market.
Traccom Inc. (OTCMKTS: TRCC) and Vocodia Holdings Inc. (OTCMKTS: VHAI) have signed a Memorandum of Understanding to form a joint venture introducing Narrative AI, a solution combining causal analysis with advanced voice AI technology. The platform integrates Vulcain's Causal AI to monitor real-time critical events and triggers immediate actionable responses when event breaches are predicted.
The system goes beyond traditional text-based alerts by enabling intelligent dialogue about impending events and recommending mitigation actions. Current applications include emergency management, logistics, healthcare, and financial risk monitoring. The partnership has established a preliminary pipeline across multiple industries and is targeting aggressive revenue growth for 2025.
Key features include real-time causal event monitoring, Response Management© with natural-sounding voice AI, cross-industry applications, and scalable integration capabilities.
Traccom Inc. (TRCC) has acquired all capital stock of Vulcain Inc. on November 13, 2024. The transaction involved issuing 117,813,680 shares of Traccom common stock, representing 95% of fully diluted shares. Vulcain, now Traccom's main operating subsidiary, added three board members including Greg Duffell as CEO, President and CFO. Vulcain specializes in Causal AI solutions, serving leading US CPG brands with plans to expand into Insurance, Healthcare, and Financial Services. The company's platform uses causal machine learning algorithms and domain experts to provide predictive outcomes for business risks and opportunities.
Traccom (OTC Pink: TRCC) has entered into a global marketing agreement with R & R Marketing Services, Inc. to promote the Traccom Basic Tracker™. This partnership leverages R & R's expertise in social media and Amazon sales to enhance market reach. The Traccom Basic Tracker aids travelers by providing real-time luggage location updates. Additionally, Traccom has developed a Remote Patient Monitoring device, the Traccom MedicalPro™, offering various health monitoring capabilities. Both products are now ready for full production.
Traccom (OTC Pink: TRCC) has signed a Supply Agreement Letter of Intent with Diabetic Direct, Inc. to supply its Traccom MedicalPro™ remote patient monitoring device. This partnership targets the substantial market of 37 million U.S. diabetics, offering a crucial opportunity for Traccom's growth. The MedicalPro™ device enables health monitoring at home, with real-time data uploaded securely for healthcare providers. Both the MedicalPro™ and the Traccom Basic™ Tracker are now ready for full production, enhancing Traccom's position in the healthcare technology sector.
Traccom (OTC Pink: TRCC) announced a price reduction for the remaining 336,228 shares in its Reg A+ Tier 2 offering, decreasing the price from $2.85 to $1.82 per share, aiming for total proceeds of approximately $601,419. The funds will be allocated primarily for inventory production and corporate operating expenses, subject to SEC approval of the post-effective amendment filed on June 17, 2022. The company is gearing up for full production of its two breakthrough products in healthcare and tracking technology.
FAQ
What is the current stock price of Traccom (TRCC)?
What is the market cap of Traccom (TRCC)?
